264 related articles for article (PubMed ID: 38198032)
1. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.
Sims NA; Lévesque JP
Curr Osteoporos Rep; 2024 Feb; 22(1):80-95. PubMed ID: 38198032
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.
Torossian F; Guerton B; Anginot A; Alexander KA; Desterke C; Soave S; Tseng HW; Arouche N; Boutin L; Kulina I; Salga M; Jose B; Pettit AR; Clay D; Rochet N; Vlachos E; Genet G; Debaud C; Denormandie P; Genet F; Sims NA; Banzet S; Levesque JP; Lataillade JJ; Le Bousse-Kerdilès MC
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093266
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.
Albiero M; Ciciliot S; Tedesco S; Menegazzo L; D'Anna M; Scattolini V; Cappellari R; Zuccolotto G; Rosato A; Cignarella A; Giorgio M; Avogaro A; Fadini GP
Diabetes; 2019 Jun; 68(6):1303-1314. PubMed ID: 30936144
[TBL] [Abstract][Full Text] [Related]
5. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.
Walker EC; McGregor NE; Poulton IJ; Solano M; Pompolo S; Fernandes TJ; Constable MJ; Nicholson GC; Zhang JG; Nicola NA; Gillespie MT; Martin TJ; Sims NA
J Clin Invest; 2010 Feb; 120(2):582-92. PubMed ID: 20051625
[TBL] [Abstract][Full Text] [Related]
7. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
[TBL] [Abstract][Full Text] [Related]
9. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
Feng Y; Yuan Y; Xia H; Wang Z; Che Y; Hu Z; Deng J; Li F; Wu Q; Bian Z; Zhou H; Shen D; Tang Q
J Transl Med; 2023 Apr; 21(1):290. PubMed ID: 37120549
[TBL] [Abstract][Full Text] [Related]
10. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
Front Immunol; 2019; 10():1164. PubMed ID: 31191537
[No Abstract] [Full Text] [Related]
11. Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.
Alexander KA; Tseng HW; Fleming W; Jose B; Salga M; Kulina I; Millard SM; Pettit AR; Genêt F; Levesque JP
Front Immunol; 2019; 10():377. PubMed ID: 30899259
[TBL] [Abstract][Full Text] [Related]
12. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
14. Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.
Jakob L; Müller TA; Rassner M; Kleinfelder H; Veratti P; Mitschke J; Miething C; Oostendorp RAJ; Pfeifer D; Waterhouse M; Duyster J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769079
[TBL] [Abstract][Full Text] [Related]
15. WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M.
Henning P; Movérare-Skrtic S; Westerlund A; Chaves de Souza PP; Floriano-Marcelino T; Nilsson KH; El Shahawy M; Ohlsson C; Lerner UH
J Inflamm Res; 2021; 14():4723-4741. PubMed ID: 34566421
[TBL] [Abstract][Full Text] [Related]
16. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of Osteoclast Formation by Oncostatin M and the Role of WNT16 as a Negative Feedback Regulator.
de Souza PPC; Henning P; Lerner UH
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328707
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
19. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.
Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F
Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310
[TBL] [Abstract][Full Text] [Related]
20. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
